APOF
Basic information
Region (hg38): 12:56360568-56362857
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the APOF gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 15 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 15 | 0 | 1 |
Variants in APOF
This is a list of pathogenic ClinVar variants found in the APOF region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-56361233-C-T | not specified | Uncertain significance (Jan 30, 2024) | ||
12-56361245-C-A | not specified | Uncertain significance (Oct 06, 2021) | ||
12-56361410-C-T | not specified | Uncertain significance (Dec 06, 2023) | ||
12-56361452-C-T | not specified | Uncertain significance (Apr 01, 2024) | ||
12-56361456-C-A | not specified | Uncertain significance (Jan 03, 2022) | ||
12-56361508-G-A | not specified | Uncertain significance (Feb 10, 2023) | ||
12-56361519-C-G | not specified | Uncertain significance (Dec 15, 2021) | ||
12-56361583-C-A | not specified | Uncertain significance (Apr 06, 2024) | ||
12-56361617-T-C | not specified | Uncertain significance (Mar 01, 2024) | ||
12-56361656-G-C | not specified | Uncertain significance (Feb 15, 2023) | ||
12-56361710-G-T | not specified | Uncertain significance (Sep 20, 2023) | ||
12-56361737-G-C | not specified | Uncertain significance (Oct 10, 2023) | ||
12-56361764-C-T | not specified | Uncertain significance (Apr 07, 2022) | ||
12-56361792-C-A | not specified | Uncertain significance (Nov 02, 2023) | ||
12-56361809-C-T | not specified | Uncertain significance (Feb 15, 2023) | ||
12-56361843-C-A | not specified | Uncertain significance (Mar 26, 2024) | ||
12-56361865-T-C | not specified | Uncertain significance (Oct 03, 2023) | ||
12-56361868-C-T | Benign (Oct 17, 2017) | |||
12-56361890-C-T | not specified | Uncertain significance (Oct 25, 2022) | ||
12-56362111-T-A | not specified | Uncertain significance (Mar 30, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
APOF | protein_coding | protein_coding | ENST00000398189 | 2 | 2255 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0103 | 0.840 | 124547 | 0 | 89 | 124636 | 0.000357 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.355 | 161 | 174 | 0.924 | 0.00000869 | 2074 |
Missense in Polyphen | 40 | 48.175 | 0.83031 | 589 | ||
Synonymous | -0.262 | 73 | 70.2 | 1.04 | 0.00000355 | 697 |
Loss of Function | 1.16 | 4 | 7.42 | 0.539 | 3.83e-7 | 83 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000419 | 0.000417 |
Ashkenazi Jewish | 0.000697 | 0.000696 |
East Asian | 0.000167 | 0.000167 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000621 | 0.000620 |
Middle Eastern | 0.000167 | 0.000167 |
South Asian | 0.0000658 | 0.0000654 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Minor apolipoprotein that associates with LDL. Inhibits cholesteryl ester transfer protein (CETP) activity and appears to be an important regulator of cholesterol transport. Also associates to a lesser degree with VLDL, Apo-AI and Apo-AII. {ECO:0000269|PubMed:9880564}.;
- Pathway
- LDL remodeling;Transport of small molecules;Plasma lipoprotein assembly, remodeling, and clearance;Plasma lipoprotein remodeling
(Consensus)
Recessive Scores
- pRec
- 0.145
Intolerance Scores
- loftool
- 0.752
- rvis_EVS
- 0.73
- rvis_percentile_EVS
- 86.08
Haploinsufficiency Scores
- pHI
- 0.245
- hipred
- N
- hipred_score
- 0.123
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.861
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Apof
- Phenotype
- liver/biliary system phenotype; homeostasis/metabolism phenotype; cellular phenotype;
Gene ontology
- Biological process
- lipid metabolic process;lipid transport;cholesterol metabolic process
- Cellular component
- extracellular space;low-density lipoprotein particle;high-density lipoprotein particle
- Molecular function
- signaling receptor binding;lipid transporter activity;cholesterol binding